Neurological disorders identified during treatment of a SARS-cov-2 infection

Shinichi Wada, Yoji Nagasaki, Yoko Arimizu, Masatoshi Shimo, Yuta Matsukuma, Masaki Okamoto, Shinichiro Yoshida, Ikkei Ohashi, Go Hashimoto, Takahiro Kuwashiro, Masahiro Yasaka, Yasushi Okada

研究成果: ジャーナルへの寄稿学術誌査読

13 被引用数 (Scopus)

抄録

A 69-year-old man was admitted to our hospital under diagnosis of pneumonia due to severe acute respiratory syndrome-corona virus 2 (SARS-CoV-2) (Day 0). He underwent endotracheal intubation from Day 3. Although his respiratory condition improved and anesthetic drugs were discontinued, no cough reflex was observed despite intubation having been performed until Day 17. His tendon reflexes were also diminished. We suspected that he had developed Guillain-Barré syndrome (GBS), and administered intravenous immunoglobulin from Day 18. The absence of cough reflex improved and extubation was successfully performed on Day 23. Neurological disorders including GBS should be considered when intubated SARS-CoV-2 patients present with a loss of cough reflex during the treatment period.

本文言語英語
ページ(範囲)2187-2189
ページ数3
ジャーナルInternal Medicine
59
17
DOI
出版ステータス出版済み - 9月 1 2020
外部発表はい

!!!All Science Journal Classification (ASJC) codes

  • 内科学

フィンガープリント

「Neurological disorders identified during treatment of a SARS-cov-2 infection」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル